semaglutide dementia Is Ozempic (Semaglutide) Lower the Risk of Dementia? Weight-loss drug semaglutide does not

The multidistrict litigation (MDL) against pharmaceutical giants Novo Nordisk and Eli Lilly, involving GLP-1 drugs such as Ozempic, Wegovy, Trulicity, and Mounjaro, continues to progress as plaintiffs claim these medications have caused serious gastrointestinal injuries

Gene editing technology has advanced impressively in recent years and is a promising gene therapy technique for the treatment of, for example, genetic diseases or cancer

doi: 10.1093/ajcn/82.1.230S

Final Thoughts Rapid weight loss through GLP-1 medications is a remarkable health achievement but it can come with aesthetic challenges that shouldnt require surgery to look refreshed and balanced